Latest California Healthline Stories
Rest Of The U.S. Could Learn ‘A Great Deal’ From Covered California, Study Says
Researchers find that the state’s exchange has succeeded by fostering competition, with a large number of insurers in the mix, aggressively negotiating on premiums and setting conditions for health plan participation.
A Deep Dive Into 4 GOP Talking Points On Health Care
The president says Obamacare has been “a complete and total disaster,” and other Republicans see nothing but trouble. But a careful look at the arguments suggest the situation is more complicated.
Former FDA Chief Cites 5 Things To Watch On Drug Approvals, And Keeping Drugs Safe
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
Drugmaker Marathon ‘Pausing’ Delivery Of $89,000-a-year Muscular Dystrophy Drug
After hearing complaints about its high price, Marathon Pharmaceuticals is pausing the launch of an $89,000 drug for a rare disease.
Death Doesn’t Have To Be So Scary
Taking time to discuss the inevitable can help conquer a universal fear.
Obamacare Came To Montana Indian Country And Brought Jobs
In remote parts of Montana, the Affordable Care Act has meant better health care for Native Americans and more job opportunities.
For California’s Smallest Businesses, Obamacare Opened The Door
The state has one of the highest rates of small business owners who get health coverage through the Affordable Care Act.
California Regulator Slams Health Insurers Over Faulty Doctor Lists
A new report finds that major insurers like Aetna and UnitedHealth submitted conflicting lists to the state that were off by thousands of doctors.
Senator Grassley Launches Inquiry Into Orphan Drugs After KHN Investigation
Citing a Kaiser Health News investigation, Senate Judiciary Committee Chairman Chuck Grassley vows to examine the orphan drug program and possible fixes.
Five Quick Ways New HHS Secretary Tom Price Could Change The Course Of Health Policy
Tom Price will have significant authority to rewrite the rules for the Affordable Care Act.